Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia

Author： Silver Henry  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.10, 2004-10, pp. : 2053-2058

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

By Dell’Osso Bernardo   Allen Andrea   Hollander Eric  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2727-2740

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence

By Zinner Norman R  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite

Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety

By Macdougall Mary   Steiner Meir  

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 161-166

Informa Healthcare

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitors and the risk of bleeding

By Weinrieb Robert M   Auriacombe Marc   Lynch Kevin G   Lewis James D  

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 337-344

Informa Healthcare

Access to resources Recommend Favorite

Selective serotonin re-uptake inhibitors in anorexia nervosa

By Vaswani Meera   Kalra Harish  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 349-357

Informa Healthcare

Access to resources Recommend Favorite